World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
52
Citations
9741
World Ranking
4064
National Ranking
355

Gareth Pryce publications per year

1983: 2 publications 1984: 4 publications 1985: 4 publications 1986: 3 publications 1987: 2 publications 1988: 2 publications 1989: 2 publications 1990: 2 publications 1991: 2 publications 1992: 1 publications 1993: 1 publications 1994: 4 publications 1995: 0 publications 1996: 3 publications 1997: 1 publications 1998: 1 publications 1999: 0 publications 2000: 2 publications 2001: 2 publications 2002: 3 publications 2003: 7 publications 2004: 3 publications 2005: 8 publications 2006: 7 publications 2007: 3 publications 2008: 7 publications 2009: 1 publications 2010: 2 publications 2011: 5 publications 2012: 5 publications 2013: 4 publications 2014: 6 publications 2015: 4 publications 2016: 6 publications 2017: 6 publications 2018: 4 publications 2019: 2 publications 2020: 9 publications 2021: 3 publications 2022: 3 publications 2023: 1 publications 2024: 1 publications
1983 2024

138 publications in total across all disciplines

Gareth Pryce publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gareth Pryce sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 131 publications — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gareth Pryce D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gareth Pryce sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 52 D-Index — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gareth Pryce is affiliated with Queen Mary University of London in the United Kingdom. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a significant focus on several specialized subfields. These include Pathology and Forensic Medicine, Immunology, Molecular Biology, Oncology, and Developmental Neuroscience.

The main topics in Gareth Pryce's work encompass Multiple Sclerosis Research Studies, Polyomavirus and related diseases, Neurogenesis and neuroplasticity mechanisms, Monoclonal and Polyclonal Antibodies Research, Immunotherapy and Immune Responses, Peripheral Neuropathies and Disorders, and Immunodeficiency and Autoimmune Disorders.

Pryce's publication record includes numerous contributions to various scientific journals. Frequent publication venues include Multiple Sclerosis and Related Disorders, bioRxiv (Cold Spring Harbor Laboratory), Clinical & Experimental Immunology, Acta Neuropathologica, and Frontiers in Immunology.

Some recent papers authored or coauthored by Pryce are:

  • COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases (2020), Clinical & Experimental Immunology
  • The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis (2020), Multiple Sclerosis and Related Disorders
  • Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis (2020), Acta Neuropathologica
  • The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies (2020), Frontiers in Immunology
  • The impact of sphingosine-1-phosphate receptor modulators on COVID-19 and SARS-CoV-2 vaccination (2022), Multiple Sclerosis and Related Disorders

Pryce frequently collaborates with other researchers in related fields. Notable coauthors include David Baker, Gavin Giovannoni, Klaus Schmierer, Angray S. Kang, and Mónica Marta.

Best Publications

  • Cannabinoids control spasticity and tremor in a multiple sclerosis model.

    D Baker;G Pryce;J L Croxford;P Brown

  • IMMUNOHISTOCHEMICAL LOCALIZATION OF CANNABINOID TYPE 1 AND VANILLOID TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 RECEPTORS IN THE MOUSE BRAIN

    L. Cristino;L. de Petrocellis;G. Pryce;D. Baker

  • Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells.

    Katarzyna Maresz;Gareth Pryce;Gareth Pryce;Eugene D Ponomarev;Giovanni Marsicano

  • Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

    Gareth Pryce;Zubair Ahmed;Deborah J. R. Hankey;Samuel J. Jackson

  • In silico patent searching reveals a new cannabinoid receptor.

    David Baker;Gareth Pryce;Wayne L. Davies;C. Robin Hiley

  • Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis

    John Greenwood;Claire E. Walters;Gareth Pryce;Naheed Kanuga

  • Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis

    David Baker;Monica Marta;Gareth Pryce;Gavin Giovannoni

  • MicroRNA-155 negatively affects blood–brain barrier function during neuroinflammation

    Miguel Alejandro Lopez-Ramirez;Dongsheng Wu;Gareth Pryce;Julie E. Simpson

  • Increasing cannabinoid levels by pharmacological and genetic manipulation delay disease progression in SOD1 mice

    Lynsey G. Bilsland;James R. T. Dick;Gareth Pryce;Stefania Petrosino

  • COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.

    D Baker;C A K Roberts;G Pryce;A S Kang

  • SV40 large T immortalised cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics

    J Greenwood;G Pryce;L Devine;D.K Male

  • Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.

    G Pryce;D Baker

  • Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis

    J M Anderson;David Hampton;R Patani;G Pryce

  • Inhibition of Rho GTPases with Protein Prenyltransferase Inhibitors Prevents Leukocyte Recruitment to the Central Nervous System and Attenuates Clinical Signs of Disease in an Animal Model of Multiple Sclerosis

    Claire E. Walters;Gareth Pryce;Deborah J. R. Hankey;Said M. Sebti

  • Lymphocyte migration into brain modelled in vitro: Control by lymphocyte activation, cytokines, and antigen☆

    David Male;Gareth Pryce;Christopher Hughes;Peter Lantos

  • Antigen presentation in brain: MHC induction on brain endothelium and astrocytes compared.

    D. K. Male;G. Pryce;C. C. W. Hughes

  • Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.

    J. Ludovic Croxford;Gareth Pryce;Gareth Pryce;Samuel J. Jackson;Samuel J. Jackson;Catherine Ledent

  • Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis

    Justin Warne;Gareth Pryce;Gareth Pryce;Julia M. Hill;Xiao Shi

  • Suppression of Autoimmune Retinal Disease by Lovastatin Does Not Require Th2 Cytokine Induction

    ME Gegg;R Harry;D Hankey;H Zambarakji

  • Cannabinoid control of neuroinflammation related to multiple sclerosis

    D Baker;S J Jackson;G Pryce

  • Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation.

    S.J. Jackson;G. Pryce;L.T. Diemel;M.L. Cuzner

Frequent Co-Authors

David Baker
David Baker University of Washington
Gavin Giovannoni
Gavin Giovannoni Queen Mary University of London
Sandra Amor
Sandra Amor University of Amsterdam
John Greenwood
John Greenwood University College London
Roger G. Pertwee
Roger G. Pertwee University of Aberdeen
Catherine Ledent
Catherine Ledent Université Libre de Bruxelles
Bert A. 't Hart
Bert A. 't Hart University of Amsterdam
Siddharthan Chandran
Siddharthan Chandran University of Edinburgh
Javier Fernández-Ruiz
Javier Fernández-Ruiz Complutense University of Madrid
Robin J.M. Franklin
Robin J.M. Franklin University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career paths. Many professionals complement their knowledge with advanced nursing roles, often through an nurse practitioner accelerated program. These programs offer a fast track to becoming advanced practitioners, blending clinical expertise with immunological principles.

Candidates without a nursing background can still pursue critical healthcare roles by enrolling in online BSN programs for non nurses. These accessible options enable a smooth transition into nursing, which is closely connected with immunology-based patient care and research.

For those seeking quicker entry into nursing, 12-month accelerated nursing programs provide an intensive path to becoming a registered nurse. These programs are ideal for motivated learners aiming to deepen their immunology knowledge alongside practical nursing skills.

Alternatively, easy LPN programs to get into offer foundational nursing education with shorter durations, suitable for those interested in supportive healthcare roles. Such pathways can serve as stepping stones into specialized immunology-related careers.

Best Scientists Citing Gareth Pryce

Trending Scientists

Recently Published Articles